Engine Biosciences
Powering New Cancer Medicines
- Business Model
- B2B
- Website
- enginebio.com
- Total Funding
- $93.6M
- Last Round
- $13.6M Series BFeb 2026
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
AI-driven drug discovery company integrating machine learning and functional genomics to develop precision medicines.
Summary
Engine Biosciences is a Biotech company. It has raised $93.6M in total across 4 rounds, most recently a $13.6M Series B round in Feb 2026. Investors include Polaris Partners, 6 Dimensions Capital and DHVC.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2026
Sign up to see all 4 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/engine-biosciences"><img src="https://indexed.vc/api/badge/company/engine-biosciences" alt="Engine Biosciences on Indexed.vc" width="260" height="76" /></a>